Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

39 results about "Disulfide Linkage" patented technology

A disulfide linkage is a covalent bond between 2 sulfide atoms from the thiol group of 2 cysteine residues (S-S). They occur both interstrand and intrastrand.

Exogenous surfactant protein B mimic

A composition including a C terminal region having residues corresponding to a peptide identified by PDB ID: 1RG3; an N terminal region having residues corresponding to a peptide identified by PDB ID: 1RG4; and a disulfide linkage between the residues near the C terminal region and the N terminal region. A composition including an exogenous peptide comprising amino acid residues comprising a C terminal region; amino acid residues comprising an N terminal region; a helix-loop-helix conformation between the residues comprising the C terminal region and the residues including the N terminal region; and at least one disulfide linkage between the residues comprising the C terminal region and the residues including N terminal region, wherein the residues including the C terminal region and the residues comprising the N terminal region have an amphiphatic property, and wherein the peptide has an a biological activity comparable to native surfactant protein SP-B. A method including delivering to a body a composition comprising an exogenous peptide having a biological activity comparable to native surfactant protein SP-B. A kit including an exogenous peptide having a biological activity comparable to native surfactant protein SP-B; and a treatment agent different from the peptide.
Owner:LOS ANGELES BIOMEDICAL RES INST AT HARBOR UCLA MEDICAL CENT

Bovine respiratory syncytial virus antigen protein

InactiveCN106432439AEffectively control and prevent lossesLoss control and preventionSsRNA viruses negative-senseVirus peptidesProtein s antigenViral Vaccine
The invention discloses bovine respiratory syncytial virus antigen protein. Compared with SEQ AAB28458.1, an amino acid sequence of the bovine respiratory syncytial virus antigen protein is characterized in that at least two sites are replaced by cysteines, the replaced cysteines are in disulfide linkage, and improvements such as disulfide linkage, hole filling and single-strand ligation on this basis. The invention further provides a method for preparing the bovine respiratory syncytial virus antigen protein. The bovine respiratory syncytial virus antigen protein and the method for preparing the same have the advantages that technologies and theories of protein crystallography are applied, structural changes of protein in a virus infection and pathopoiesis process are determined, and the key viral protein is subjected to genetic engineering modifications according to structural change results so as to become the antigen protein which is infectious but not pathogenic and capable of causing high-efficiency reaction of animal antigens; the bovine respiratory syncytial virus antigen protein is capable of effectively preventing and treating bovine respiratory syncytial virus infection and is developed into satisfactory viral vaccines on the basis to control and prevent loss brought by virus infection, thereby being of great economic and social significance.
Owner:烟台偌帝生物工程有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products